Short answer
CARLSMED, INC. (CARL) filed an 8-K current report with the SEC on May 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q1 2026 results covered quarter ended March 31, 2026.
CARLSMED, INC. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q1 2026 results covered quarter ended March 31, 2026
- Press release furnished as Exhibit 99.1 contains the financial results and operating details
- Results announcement dated May 5, 2026
Item EX-99.1 · Exhibit EX-99.1
- Q1 2026 revenue $16.1M, up 58.2% year over year, indicating strong commercial adoption of personalized spine products
- Gross margin improved to 77.1% from 74.9%, supporting attractive unit economics as revenue scales
- Operating expenses rose to $21.7M, driving net loss of $8.7M versus $5.7M; adjusted EBITDA loss widened to $7.5M
- Cash, restricted cash and short-term investments totaled $97.1M at March 31, 2026, providing funding for continued expansion
- Full-year revenue guidance raised to $72M-$77M from $70M-$75M, with midpoint growth of 48% over 2025
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other CARLSMED, INC. 8-K filings
Get the next CARL 8-K as it lands
Follow CARL for push alerts, or ask the research agent what this filing means.